Hua Medicine Announces the Pharmaceutical Service of Hong Kong Department of Health of China has Officially Accepted the Application for Marketing Authorization of the New Drug Dorzagliatin Sep 29, 2025 11:22 HKT/SGT Hua Medicine ("the Company", HKEX: 2552) announced that the Department of Health of the Hong Kong Special Administrative...
Hua Medicine Announces 2025 Interim Results Aug 28, 2025 18:07 JST Hua Medicine (the "Company", HKEx: 2552) announced the unaudited consolidated results of the Company and its subsidiaries...
Hua Medicine Announces 2025 Interim Results Aug 28, 2025 17:07 HKT/SGT Hua Medicine (the "Company", HKEx: 2552) announced the unaudited consolidated results of the Company and its subsidiaries...
Hua Medicine Announces at 2025 ADA Scientific Sessions that Dorzagliatin Combined with DPP-4 Inhibitor Shows Promise in Reducing Blood Lipids While Restoring Glucose Homeostasis Jun 23, 2025 12:05 HKT/SGT Hua Medicine ("the Company", stock code: 2552.HK <https://2552.HK>) announced today that the Company presented...
Hua Medicine Announces 2024 Annual Results Mar 28, 2025 22:51 JST Hua Medicine ("the Company", Hong Kong Stock Exchange Stock Code: 2552) announced the audited full-year results...
Hua Medicine Announces 2024 Annual Results Mar 28, 2025 21:51 HKT/SGT Hua Medicine ("the Company", Hong Kong Stock Exchange Stock Code: 2552) announced the audited full-year results...
Dr. Li Chen Honored as A Leading Figure in Shanghai's Industry and Commerce Mar 18, 2025 22:36 HKT/SGT On March 17th, the highly anticipated 7th Commendation and Exchange Conference for the Leading Figures in Shanghai's Industry...
Hua Medicine Awarded Shanghai Innovative Enterprise Headquarters Mar 03, 2025 14:50 HKT/SGT On February 27th, the awarding ceremony of the second batch of Shanghai Innovative Enterprise Headquarters was held in Shanghai.
Hua Medicine Announces Successful U.S. Phase I Results on Its 2nd Generation GKA Candidate Nov 30, 2024 21:08 HKT/SGT Hua Medicine (the "Company", HKEx stock code: 2552) announced today that the Company has successfully completed...
Hua Medicine Announces Successful H.K. SENSITIZE Study Results at the CBIIC Nov 30, 2024 20:34 HKT/SGT Hua Medicine (the "Company", HKEx stock code: 2552) announced today that the Company has successfully completed...